Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
100.49
+6.69 (7.13%)
At close: Dec 5, 2025, 4:00 PM EST
102.49
+2.00 (1.99%)
After-hours: Dec 5, 2025, 5:49 PM EST

Palvella Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22
Market Capitalization
1,189135--
Enterprise Value
1,142215--
Last Close Price
100.4912.00--
PB Ratio
28.812.15--
P/TBV Ratio
30.752.15--
Debt / Equity Ratio
0.410.19-2.08-1.40
Quick Ratio
6.387.143.112.78
Current Ratio
6.497.333.202.86
Return on Equity (ROE)
-301.19%-59.37%--
Return on Assets (ROA)
-47.54%-18.39%-61.63%-
Return on Capital (ROIC)
-63.87%-22.38%-110.58%-
Return on Capital Employed (ROCE)
-55.90%-18.50%-228.80%-167.90%
Earnings Yield
-2.72%-12.95%--
Buyback Yield / Dilution
-60.51%-24.08%68.63%-
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q